ID: ALA5271586

Max Phase: Preclinical

Molecular Formula: C12H10FN3OS2

Molecular Weight: 295.36

Associated Items:

Representations

Canonical SMILES:  O=C(NNC(=S)Nc1ccc(F)cc1)c1cccs1

Standard InChI:  InChI=1S/C12H10FN3OS2/c13-8-3-5-9(6-4-8)14-12(18)16-15-11(17)10-2-1-7-19-10/h1-7H,(H,15,17)(H2,14,16,18)

Standard InChI Key:  SAOIIQOJJODFKQ-UHFFFAOYSA-N

Associated Targets(non-human)

Toxoplasma gondii 4585 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 295.36Molecular Weight (Monoisotopic): 295.0249AlogP: 2.52#Rotatable Bonds: 2
Polar Surface Area: 53.16Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.17CX Basic pKa: CX LogP: 3.09CX LogD: 3.08
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.59Np Likeness Score: -3.06

References

1. Wu RZ, Zhou HY, Song JF, Xia QH, Hu W, Mou XD, Li X..  (2021)  Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations.,  64  (24.0): [PMID:34894691] [10.1021/acs.jmedchem.1c01569]

Source